Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 744 All time
- Disclosed funding
- $25.4B 609 disclosed amounts
- Median round
- $16M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| HH Handl HealthCompany profile Provides technology platform for designing employer-sponsored health insurance Provides technology platform for designing employer-sponsored health insurance | $14.2M | Series A | Healthtech | United States | Investors | |
| CT Centauri TherapeuticsCompany profile Develops immunotherapeutic treatments for antimicrobial infections Develops immunotherapeutic treatments for antimicrobial infections | £6M | Series A+Series A | Healthtech, Biotech | United Kingdom | Investors | |
| CC Provides in-home pediatric speech, occupational, and physical therapy | $13M | Series A | Healthtech | United States | Investors | |
| P Enables safe and compliant use of medical imaging data for research and AI | £357K | Seed | Healthtech | United Kingdom | Investors | |
| F FlinnCompany profile Develops AI-based software to automate regulatory and quality processes in medtech and pharma Develops AI-based software to automate regulatory and quality processes in medtech and pharma | $20M | Series A | Healthtech | Austria | Investors | |
| KB Develops therapies for neurodegenerative diseases. | $175M | Series A | Healthtech, Biotech | United States | Investors | |
| SP Develops next-generation peptide radioligand therapies for cancer | $18M | Series A | Healthtech, Biotech | United States | Investors | |
| PS ProSomnus Sleep TechnologiesCompany profile Provides non-CPAP alternative for Obstructive Sleep Apnea treatment Provides non-CPAP alternative for Obstructive Sleep Apnea treatment | $38M | StrategicUndisclosed | Healthtech | United States | Investors | |
| SM Synchrony MedicalCompany profile Provides at-home airway clearance therapy for chronic respiratory disease Provides at-home airway clearance therapy for chronic respiratory disease | $5M | Seed | Healthtech | United States | Investors | |
| EM Develops image-enabled technologies for complex coronary interventions | Undisclosed | Series CSeries C+ | Healthtech | United States | Investors Undisclosed |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →